メリーランド州における高血圧の臨床試験
メリーランド州内の拠点で、高血圧に関する18件の研究が参加者を募集しています。
メリーランド州内の都市
公式研究テキスト（英語）
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
7歳〜70歳 · 全性別 · 2026/10/02更新 · NCT03374215BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- The Johns Hopkins University, Baltimore
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT06059638EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Ascension Saint Agnes Heart Care, Baltimore
- Medstar Montgomery Medical Center, Olney
- MD Medical Research, Oxon Hill
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Centennial Medical Group, Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579Diabetes and Heart Disease Risk in Blacks
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
18歳〜70歳 · 全性別 · 2026/09/28更新 · NCT00001853A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Bethesda
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06742723Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Baltimore
- Clinical Trial Site, Baltimore
- Clinical Trial Site, Baltimore
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07181109Implementation of a Beauty Salon-Based Strategy for Blood Pressure Management Among Women
- Johns Hopkins University, Baltimore
被験者募集中健康なボランティア歓迎参加者への支払いあり
18歳〜79歳 · 女性 · 2026/09/08更新 · NCT07042386Childhood-Onset Essential Hypertension Natural History Study
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究
2歳〜99歳 · 全性別 · 2026/09/03更新 · NCT06778239Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第2相
18歳〜100歳 · 全性別 · 2026/08/25更新 · NCT03206060Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
- Frederick Memorial Hospital, Frederick
被験者募集中観察研究
18歳〜100歳 · 全性別 · 2026/08/07更新 · NCT06402968An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Anderson Medical Research, Ft. Washington
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT07543120A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Anderson Medical Research, Ft. Washington
- Capitol Cardiology Associates, Lanham
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/07/30更新 · NCT07610278Integrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure
- Johns Hopkins Community Physicians, Baltimore
- Johns Hopkins School of Nursing, Baltimore
- Holy Cross Hospital, Gaithersburg
被験者募集中健康なボランティア歓迎
21歳〜70歳 · 全性別 · 2026/06/30更新 · NCT07075588Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes
- Johns Hopkins ProHealth Clinical Research Unit, Baltimore
被験者募集中
18歳以上 · 全性別 · 2026/03/24更新 · NCT06921356Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
- Johns Hopkins University School of Medicine, Baltimore
被験者募集中第4相
18歳以上 · 全性別 · 2026/03/05更新 · NCT07247058Imaging the Pathogenesis of Cerebral Small Vessel Disease
- Kennedy Krieger Institute, Baltimore
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/03更新 · NCT05703386A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
- Johns Hopkins Community Physicians, Baltimore
被験者募集中
18歳以上 · 全性別 · 2025/10/09更新 · NCT05321368ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。